Back to Results
First PageMeta Content
Motor neurone disease / Health / ALS Association / Amyotrophic lateral sclerosis / SOD1 / ALS Therapy Development Institute / Rare diseases / James Heywood


Bridging Traditional & Translational Research Challenges in ALS: The Brick-and-Mortar Non-Profit Biotech: A New Paradigm for Medical Research NOTE: Nothing in this deck should be considered medical advice. Please review
Add to Reading List

Document Date: 2011-10-11 15:40:29

Open Document

File Size: 2,34 MB

Share Result on Facebook

City

Cambridge / /

Company

ALS Therapy Development Institute Inc. / TDI / ALS Therapy Development Foundation Inc. / ALS TDI / /

Currency

USD / /

/

Facility

Dana-Farber Cancer Institute / Current pipeline / sp/ft Institute / ALS Therapy Development Institute / Harvard University / /

IndustryTerm

industrial scale pharmaceutical development / 501c3 nonprofit biotechnology / pharmaceutical partnerships / /

MedicalCondition

ALS / /

Organization

Lance Armstrong Foundation / ALS Association / sp/ft Institute / Harvard University / Scientific Review Board / Muscular Dystrophy Association / Les Turner ALS Foundation / Multiple Myeloma Research Foundation / Alzheimer's Association / ALS Therapy Development Foundation / ALS Therapy Development Institute / Cystic Fibrosis Foundation / Executive Board / Scientific Board / Dana-Farber Cancer Institute / /

Person

J.D. Sharon Hesterlee / Lee Sweeney / Leslie Michelson / Steve Perrin / Spiros Jamas / Stan Appel / J.D. Jamie Heywood John Heywood / Rob Rodin Alex Cappello / J.D. Ted Reich / M.D. John McCoy / Robert A. Goldstein / /

/

Position

Augie Nieto Vice Chair / Chairman / TDI Executive / physician / /

Technology

biotechnology / Drug Development / /

URL

www.als.net / /

SocialTag